In the BioHarmony Drug Report Database

"Preview" Icon

Itraconazole

Onmel, Sporanox, Tolsura (itraconazole) is a small molecule pharmaceutical. Itraconazole was first approved as Onmel on 1992-09-11. It is used to treat aids-related opportunistic infections, aspergillosis, blastomycosis, chronic mucocutaneous candidiasis, and coccidioidomycosis amongst others in the USA. Sporanox’s patents are valid until 2033-06-21 (FDA).

 

Trade Name

 

Onmel, Sporanox, Tolsura
 

Common Name

 

itraconazole
 

ChEMBL ID

 

CHEMBL64391
 

Indication

 

aids-related opportunistic infections, aspergillosis, blastomycosis, chronic mucocutaneous candidiasis, coccidioidomycosis, cryptococcosis, histoplasmosis, leishmaniasis, mycoses, neutropenia, onychomycosis, oral candidiasis, paracoccidioidomycosis, sporotrichosis, vulvovaginal candidiasis, zygomycosis
 

Drug Class

 

Systemic antifungals (miconazole type)

Image (chem structure or protein)

Itraconazole structure rendering